Be Vigilant When Starting Meds in Patients Taking Hep C Antivirals

July 2019

You'll face MANY potential drug interactions with hepatitis C antivirals (Epclusa, Mavyret, etc)...even if you didn't start these meds.

Interactions can lead to toxicity...or treatment failure. And this can be an expensive mistake...since antivirals cost up to $95,000/course.

Plus hep C meds may fly under the radar if you didn't prescribe them. Update the EHR with ALL meds...Rxs, OTCs, supplements, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote